link_id stringlengths 25 25 | evidence_group_id stringlengths 22 22 | pmid int64 1.8M 42.2M | nct_id stringlengths 11 11 | claim_type stringclasses 6
values | claim_direction stringclasses 6
values | claim_strength stringclasses 3
values | n_results int64 0 126 | outcome_types_present stringclasses 5
values | result_ids stringclasses 249
values | checkability stringclasses 2
values | verification stringclasses 1
value | evidence_span stringclasses 21
values |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLAIM_RESULT_602e514bbfa1 | CLUST_9c76d8d2398ea3da | 27,871,643 | NCT02076425 | association_claim | improved | directionally_supported | 3 | OTHER_PRE_SPECIFIED; PRIMARY; SECONDARY | RESULT_510d7a0679bd; RESULT_ff3353871dcd; RESULT_f5a2fb0b293d | checkable | not_assessed | associated with |
CLAIM_RESULT_ed4041fe312e | CLUST_451956d475ce3c85 | 27,835,713 | NCT00324701 | non_inferiority_claim | non_inferior | directionally_supported | 2 | PRIMARY; SECONDARY | RESULT_97c20874ba3d; RESULT_4a228f4364f2 | checkable | not_assessed | noninferior |
CLAIM_RESULT_69763969eb68 | CLUST_42cf28b90f23786c | 27,718,369 | NCT00088699 | association_claim | improved | source_reported | 2 | PRIMARY | RESULT_35dc96b4efd4; RESULT_29d3fd110100 | checkable | not_assessed | increased |
CLAIM_RESULT_eed6172245b2 | CLUST_42cf28b90f23786c | 27,718,369 | NCT00088699 | association_claim | improved | directionally_supported | 2 | PRIMARY | RESULT_35dc96b4efd4; RESULT_29d3fd110100 | checkable | not_assessed | associated with |
CLAIM_RESULT_bd20518466e6 | CLUST_a7b81a5c9883a873 | 27,788,313 | NCT00767624 | superiority_claim | improved | statistically_supported | 2 | PRIMARY; SECONDARY | RESULT_3d51c3b25792; RESULT_af796ddbed3c | checkable | not_assessed | superior to |
CLAIM_RESULT_13f866621db3 | CLUST_a7b81a5c9883a873 | 27,788,313 | NCT00767624 | efficacy_claim | improved | statistically_supported | 2 | PRIMARY; SECONDARY | RESULT_3d51c3b25792; RESULT_af796ddbed3c | checkable | not_assessed | efficacy |
CLAIM_RESULT_47a9a5103417 | CLUST_eb89673b1dd9404b | 27,631,145 | NCT00854542 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_f80b88400950 | CLUST_4e7a026f3ab4be13 | 27,631,142 | NCT00021528 | association_claim | associated | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | increased |
CLAIM_RESULT_977622c5f7cd | CLUST_4e7a026f3ab4be13 | 27,631,142 | NCT00021528 | association_claim | associated | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_f770e328235b | CLUST_5bfa4a9d445ed1f3 | 27,529,765 | NCT01545843 | no_difference_claim | no_difference | statistically_supported | 8 | PRIMARY; SECONDARY | RESULT_2d48aa67232a; RESULT_c1964a40f425; RESULT_7412804334d0; RESULT_3b8e6bc282fc; RESULT_7f1d7ba549f5; RESULT_b594073a72d7; RESULT_8bb26c5d4ab3; RESULT_e787ae4dcd0d | checkable | not_assessed | no difference |
CLAIM_RESULT_3f7d965e5bd7 | CLUST_26c3c2e6b5554e6a | 27,781,135 | NCT02013531 | superiority_claim | unclear | statistically_supported | 19 | PRIMARY; SECONDARY | RESULT_e4c08e1d6e90; RESULT_98983dc01067; RESULT_c2f4e84797c1; RESULT_70cab6ef129b; RESULT_eaee0f2e376a; RESULT_8ef92b874222; RESULT_a4705b7d317c; RESULT_284f2f9595db; RESULT_6205bae5f356; RESULT_d0559e2d138b; RESULT_26c0721b3518; RESULT_a8dd996c4838; RESULT_d926f3106185; RESULT_e29d49e8ac84; RESULT_b744559c7b48; RESUL... | checkable | not_assessed | increased |
CLAIM_RESULT_c7f4ac1522db | CLUST_26c3c2e6b5554e6a | 27,781,135 | NCT02013531 | safety_claim | unclear | statistically_supported | 19 | PRIMARY; SECONDARY | RESULT_e4c08e1d6e90; RESULT_98983dc01067; RESULT_c2f4e84797c1; RESULT_70cab6ef129b; RESULT_eaee0f2e376a; RESULT_8ef92b874222; RESULT_a4705b7d317c; RESULT_284f2f9595db; RESULT_6205bae5f356; RESULT_d0559e2d138b; RESULT_26c0721b3518; RESULT_a8dd996c4838; RESULT_d926f3106185; RESULT_e29d49e8ac84; RESULT_b744559c7b48; RESUL... | checkable | not_assessed | well tolerated |
CLAIM_RESULT_f6074854b680 | CLUST_26c3c2e6b5554e6a | 27,781,135 | NCT02013531 | efficacy_claim | unclear | statistically_supported | 19 | PRIMARY; SECONDARY | RESULT_e4c08e1d6e90; RESULT_98983dc01067; RESULT_c2f4e84797c1; RESULT_70cab6ef129b; RESULT_eaee0f2e376a; RESULT_8ef92b874222; RESULT_a4705b7d317c; RESULT_284f2f9595db; RESULT_6205bae5f356; RESULT_d0559e2d138b; RESULT_26c0721b3518; RESULT_a8dd996c4838; RESULT_d926f3106185; RESULT_e29d49e8ac84; RESULT_b744559c7b48; RESUL... | checkable | not_assessed | efficacy |
CLAIM_RESULT_ff034d824291 | CLUST_5ce4c2a06f53ff0f | 27,379,563 | NCT01325831 | superiority_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | reduced |
CLAIM_RESULT_7b636337434f | CLUST_254d98880535ff98 | 27,654,449 | NCT01140464 | superiority_claim | unclear | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | increased |
CLAIM_RESULT_84df0ac17770 | CLUST_254d98880535ff98 | 27,654,449 | NCT01140464 | efficacy_claim | unclear | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | effective in |
CLAIM_RESULT_ce39338327ed | CLUST_f08fcb3a7589babc | 27,630,014 | NCT02166424 | efficacy_claim | unclear | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_c5591ed20e9c | CLUST_b08a9ecd19100795 | 27,626,622 | NCT00704379 | superiority_claim | associated | statistically_supported | 6 | PRIMARY; SECONDARY | RESULT_d4a2d705d579; RESULT_08e1c2fe7fa7; RESULT_a57b6316c19d; RESULT_195e28c28392; RESULT_8d70012c8cc9; RESULT_6fde7558d77e | checkable | not_assessed | more effective than |
CLAIM_RESULT_6bc153b92f76 | CLUST_b08a9ecd19100795 | 27,626,622 | NCT00704379 | safety_claim | associated | statistically_supported | 6 | PRIMARY; SECONDARY | RESULT_d4a2d705d579; RESULT_08e1c2fe7fa7; RESULT_a57b6316c19d; RESULT_195e28c28392; RESULT_8d70012c8cc9; RESULT_6fde7558d77e | checkable | not_assessed | well tolerated |
CLAIM_RESULT_103388afc642 | CLUST_b08a9ecd19100795 | 27,626,622 | NCT00704379 | association_claim | associated | source_reported | 6 | PRIMARY; SECONDARY | RESULT_d4a2d705d579; RESULT_08e1c2fe7fa7; RESULT_a57b6316c19d; RESULT_195e28c28392; RESULT_8d70012c8cc9; RESULT_6fde7558d77e | checkable | not_assessed | associated with |
CLAIM_RESULT_5289a61518a8 | CLUST_b08a9ecd19100795 | 27,626,622 | NCT00704379 | efficacy_claim | associated | statistically_supported | 6 | PRIMARY; SECONDARY | RESULT_d4a2d705d579; RESULT_08e1c2fe7fa7; RESULT_a57b6316c19d; RESULT_195e28c28392; RESULT_8d70012c8cc9; RESULT_6fde7558d77e | checkable | not_assessed | efficacy |
CLAIM_RESULT_00cea6dbc85f | CLUST_eb89673b1dd9404b | 27,561,153 | NCT00854542 | efficacy_claim | unclear | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | effective in |
CLAIM_RESULT_dc6f7ffb5126 | CLUST_4e7a026f3ab4be13 | 27,503,474 | NCT02628054 | superiority_claim | associated | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | increased |
CLAIM_RESULT_5afed4cf3f0f | CLUST_4e7a026f3ab4be13 | 27,503,474 | NCT02628054 | association_claim | associated | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_7200574bbd16 | CLUST_4e7a026f3ab4be13 | 27,498,098 | NCT01047124 | no_difference_claim | no_difference | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | no significant difference |
CLAIM_RESULT_531ce808d26b | CLUST_4e7a026f3ab4be13 | 27,498,098 | NCT01047124 | efficacy_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_2414f4e100cd | CLUST_4ac918e56e5082e8 | 27,488,181 | NCT02361684 | non_inferiority_claim | non_inferior | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | non-inferior |
CLAIM_RESULT_e57c054c6168 | CLUST_4ac918e56e5082e8 | 27,488,181 | NCT02389660 | non_inferiority_claim | non_inferior | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | non-inferior |
CLAIM_RESULT_6602c9ac039b | CLUST_4ac918e56e5082e8 | 27,488,181 | NCT02410616 | non_inferiority_claim | non_inferior | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | non-inferior |
CLAIM_RESULT_219e08daa953 | CLUST_4ac918e56e5082e8 | 27,488,181 | NCT02449447 | non_inferiority_claim | non_inferior | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | non-inferior |
CLAIM_RESULT_69a8f23d1c5b | CLUST_4ac918e56e5082e8 | 27,488,181 | NCT02542891 | non_inferiority_claim | non_inferior | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | non-inferior |
CLAIM_RESULT_5a6cb950c397 | CLUST_1c2f0cd6ea0c7533 | 27,487,573 | NCT01207271 | non_inferiority_claim | unclear | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | not inferior |
CLAIM_RESULT_cf69b0f16981 | CLUST_081d2de58561fa67 | 27,486,544 | NCT01629966 | efficacy_claim | unclear | statistically_supported | 2 | PRIMARY; SECONDARY | RESULT_8e2661b23a25; RESULT_61c16b6818fb | checkable | not_assessed | effective in |
CLAIM_RESULT_ff618ce79874 | CLUST_081d2de58561fa67 | 27,486,544 | NCT01766401 | efficacy_claim | unclear | statistically_supported | 2 | PRIMARY; SECONDARY | RESULT_ee21b55974d4; RESULT_adc02ff5ef2c | checkable | not_assessed | effective in |
CLAIM_RESULT_f0798bc8cc56 | CLUST_081d2de58561fa67 | 27,486,544 | NCT01844115 | efficacy_claim | unclear | statistically_supported | 2 | PRIMARY; SECONDARY | RESULT_c5112a0e64bd; RESULT_a98eb476ee16 | checkable | not_assessed | effective in |
CLAIM_RESULT_6d0990110056 | CLUST_2d671a0c3c16e6b9 | 27,485,050 | NCT00711971 | association_claim | associated | source_reported | 9 | OTHER_PRE_SPECIFIED; PRIMARY | RESULT_6a6079f77711; RESULT_44537ae5d3a4; RESULT_9ce7a529334f; RESULT_e1cd5dd26b42; RESULT_d0bb68963e8c; RESULT_9a0f86869739; RESULT_7c4b47ec57d4; RESULT_0f1cfe140d86; RESULT_6b97a945a089 | checkable | not_assessed | associated with |
CLAIM_RESULT_b496ea2be928 | CLUST_8f29eb653a74cfc7 | 27,422,150 | NCT02023567 | association_claim | associated | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_75b2bce8f8b1 | CLUST_c62369535e0d5f62 | 27,379,823 | NCT01942785 | safety_claim | improved | directionally_supported | 26 | PRIMARY | RESULT_f121f780c2d9; RESULT_fd94ecf08fe7; RESULT_eeb477efb4eb; RESULT_de619e13bb15; RESULT_26f850248813; RESULT_634dd3aa5a21; RESULT_fea100bc58b5; RESULT_599a34358f57; RESULT_66ca0810c5ab; RESULT_aaefcc23b65d; RESULT_247aabcf7349; RESULT_f2515e22f928; RESULT_d47e36dad30b; RESULT_984223444f14; RESULT_226c9850ae8a; RESUL... | checkable | not_assessed | well tolerated |
CLAIM_RESULT_4f70d4c7ae21 | CLUST_8f4bcc165e63fd8e | 27,362,792 | NCT02407652 | superiority_claim | worsened | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | increased |
CLAIM_RESULT_e59c744b1e78 | CLUST_0574f8d72b745bfe | 27,304,433 | NCT01437657 | no_difference_claim | no_difference | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | no difference |
CLAIM_RESULT_97cdfa60ff7d | CLUST_0574f8d72b745bfe | 27,304,433 | NCT01437657 | efficacy_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_931c75f7d20a | CLUST_90c2c4cc8152e91c | 27,280,963 | NCT01468610 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_02dbc8ebba5d | CLUST_90c2c4cc8152e91c | 27,280,963 | NCT01468610 | association_claim | improved | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | improved outcomes |
CLAIM_RESULT_c3f2b5f59bff | CLUST_b803dd80a15a1db9 | 27,276,373 | NCT01179568 | efficacy_claim | improved | statistically_supported | 5 | PRIMARY; SECONDARY | RESULT_1cc6dc2b6d95; RESULT_c66db9d04187; RESULT_262e28442a9f; RESULT_cdda36d3751a; RESULT_ff1677e0372f | checkable | not_assessed | efficacy |
CLAIM_RESULT_17d63a3e2b94 | CLUST_c019473956d4ec09 | 27,238,068 | NCT00919594 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_774e52d47a7d | CLUST_081d2de58561fa67 | 27,232,052 | NCT01844115 | safety_claim | unclear | statistically_supported | 2 | PRIMARY; SECONDARY | RESULT_c5112a0e64bd; RESULT_a98eb476ee16 | checkable | not_assessed | well tolerated |
CLAIM_RESULT_0782f13c8740 | CLUST_081d2de58561fa67 | 27,232,052 | NCT01844115 | efficacy_claim | unclear | statistically_supported | 2 | PRIMARY; SECONDARY | RESULT_c5112a0e64bd; RESULT_a98eb476ee16 | checkable | not_assessed | efficacy |
CLAIM_RESULT_651fa5c66c2c | CLUST_466eba9709771c78 | 27,208,498 | NCT01360632 | superiority_claim | associated | statistically_supported | 24 | PRIMARY; SECONDARY | RESULT_56eabbfd9dc0; RESULT_a99361d4e140; RESULT_c57ab643c9cb; RESULT_95717e1e7fc6; RESULT_9851fa1ed5b4; RESULT_0e0fc694c62a; RESULT_4fb718df1574; RESULT_e2a892cea259; RESULT_54da2c1d81aa; RESULT_f880e622bd02; RESULT_f2e5d7ecc1c5; RESULT_847a4d430abf; RESULT_838ba3770777; RESULT_ba851d5bd541; RESULT_3c1710f3ca56; RESUL... | checkable | not_assessed | increased |
CLAIM_RESULT_bc4fdcc4204b | CLUST_466eba9709771c78 | 27,208,498 | NCT01360632 | safety_claim | associated | statistically_supported | 24 | PRIMARY; SECONDARY | RESULT_56eabbfd9dc0; RESULT_a99361d4e140; RESULT_c57ab643c9cb; RESULT_95717e1e7fc6; RESULT_9851fa1ed5b4; RESULT_0e0fc694c62a; RESULT_4fb718df1574; RESULT_e2a892cea259; RESULT_54da2c1d81aa; RESULT_f880e622bd02; RESULT_f2e5d7ecc1c5; RESULT_847a4d430abf; RESULT_838ba3770777; RESULT_ba851d5bd541; RESULT_3c1710f3ca56; RESUL... | checkable | not_assessed | well tolerated |
CLAIM_RESULT_6ea19bf44b9a | CLUST_466eba9709771c78 | 27,208,498 | NCT01360632 | association_claim | associated | source_reported | 24 | PRIMARY; SECONDARY | RESULT_56eabbfd9dc0; RESULT_a99361d4e140; RESULT_c57ab643c9cb; RESULT_95717e1e7fc6; RESULT_9851fa1ed5b4; RESULT_0e0fc694c62a; RESULT_4fb718df1574; RESULT_e2a892cea259; RESULT_54da2c1d81aa; RESULT_f880e622bd02; RESULT_f2e5d7ecc1c5; RESULT_847a4d430abf; RESULT_838ba3770777; RESULT_ba851d5bd541; RESULT_3c1710f3ca56; RESUL... | checkable | not_assessed | associated with |
CLAIM_RESULT_f4f8b9f81d1c | CLUST_466eba9709771c78 | 27,208,498 | NCT01360632 | efficacy_claim | associated | statistically_supported | 24 | PRIMARY; SECONDARY | RESULT_56eabbfd9dc0; RESULT_a99361d4e140; RESULT_c57ab643c9cb; RESULT_95717e1e7fc6; RESULT_9851fa1ed5b4; RESULT_0e0fc694c62a; RESULT_4fb718df1574; RESULT_e2a892cea259; RESULT_54da2c1d81aa; RESULT_f880e622bd02; RESULT_f2e5d7ecc1c5; RESULT_847a4d430abf; RESULT_838ba3770777; RESULT_ba851d5bd541; RESULT_3c1710f3ca56; RESUL... | checkable | not_assessed | efficacy |
CLAIM_RESULT_792fcf6974a6 | CLUST_466eba9709771c78 | 27,208,498 | NCT01360645 | superiority_claim | associated | statistically_supported | 24 | PRIMARY; SECONDARY | RESULT_c0243b6955a4; RESULT_3d42ceaae613; RESULT_4f597d614bcc; RESULT_19e598628adf; RESULT_beab72d1cbec; RESULT_30b266c84384; RESULT_71aecdaa431b; RESULT_9f252ed18c6b; RESULT_fc4323d68852; RESULT_a1af5c67f06d; RESULT_08329a926d84; RESULT_8b788683e322; RESULT_2e463e3b30b9; RESULT_bed7dbc6c76d; RESULT_8a07763656a2; RESUL... | checkable | not_assessed | increased |
CLAIM_RESULT_3d0874c676cb | CLUST_466eba9709771c78 | 27,208,498 | NCT01360645 | safety_claim | associated | statistically_supported | 24 | PRIMARY; SECONDARY | RESULT_c0243b6955a4; RESULT_3d42ceaae613; RESULT_4f597d614bcc; RESULT_19e598628adf; RESULT_beab72d1cbec; RESULT_30b266c84384; RESULT_71aecdaa431b; RESULT_9f252ed18c6b; RESULT_fc4323d68852; RESULT_a1af5c67f06d; RESULT_08329a926d84; RESULT_8b788683e322; RESULT_2e463e3b30b9; RESULT_bed7dbc6c76d; RESULT_8a07763656a2; RESUL... | checkable | not_assessed | well tolerated |
CLAIM_RESULT_c1533df08d27 | CLUST_466eba9709771c78 | 27,208,498 | NCT01360645 | association_claim | associated | source_reported | 24 | PRIMARY; SECONDARY | RESULT_c0243b6955a4; RESULT_3d42ceaae613; RESULT_4f597d614bcc; RESULT_19e598628adf; RESULT_beab72d1cbec; RESULT_30b266c84384; RESULT_71aecdaa431b; RESULT_9f252ed18c6b; RESULT_fc4323d68852; RESULT_a1af5c67f06d; RESULT_08329a926d84; RESULT_8b788683e322; RESULT_2e463e3b30b9; RESULT_bed7dbc6c76d; RESULT_8a07763656a2; RESUL... | checkable | not_assessed | associated with |
CLAIM_RESULT_40641f70a7b3 | CLUST_466eba9709771c78 | 27,208,498 | NCT01360645 | efficacy_claim | associated | statistically_supported | 24 | PRIMARY; SECONDARY | RESULT_c0243b6955a4; RESULT_3d42ceaae613; RESULT_4f597d614bcc; RESULT_19e598628adf; RESULT_beab72d1cbec; RESULT_30b266c84384; RESULT_71aecdaa431b; RESULT_9f252ed18c6b; RESULT_fc4323d68852; RESULT_a1af5c67f06d; RESULT_08329a926d84; RESULT_8b788683e322; RESULT_2e463e3b30b9; RESULT_bed7dbc6c76d; RESULT_8a07763656a2; RESUL... | checkable | not_assessed | efficacy |
CLAIM_RESULT_96f6a40c9f8e | CLUST_804bcdc1c60f2db5 | 27,172,277 | NCT01625546 | superiority_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | reduced |
CLAIM_RESULT_b0848a2899a3 | CLUST_804bcdc1c60f2db5 | 27,172,277 | NCT01625546 | efficacy_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_e3564f5a93d9 | CLUST_774f0007100eaebf | 27,152,523 | NCT02427789 | superiority_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | increased |
CLAIM_RESULT_e789298265a3 | CLUST_774f0007100eaebf | 27,152,523 | NCT02427789 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_ee1330645930 | CLUST_774f0007100eaebf | 27,152,523 | NCT02427789 | efficacy_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_ded5dc9d2153 | CLUST_e2335472d68c3298 | 27,150,464 | NCT01272531 | association_claim | associated | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_cca9eed8fe67 | CLUST_e2335472d68c3298 | 27,150,464 | NCT01272531 | efficacy_claim | associated | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_d0920408afc0 | CLUST_cf2a649e288211e0 | 27,137,422 | NCT00251043 | superiority_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | more effective than |
CLAIM_RESULT_57b00929814d | CLUST_cf2a649e288211e0 | 27,137,422 | NCT00251043 | no_difference_claim | no_difference | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | no significant difference |
CLAIM_RESULT_c602c8c8fdd7 | CLUST_a8820dfa781290d4 | 27,133,029 | NCT01046630 | superiority_claim | unclear | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | increased |
CLAIM_RESULT_20df07a20486 | CLUST_a8820dfa781290d4 | 27,133,029 | NCT01046630 | efficacy_claim | unclear | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_4cc07ed10357 | CLUST_4e7a026f3ab4be13 | 27,124,715 | NCT00021528 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_3eb666fc2f7d | CLUST_31214ff48de12f76 | 27,103,215 | NCT01542957 | superiority_claim | improved | directionally_supported | 3 | PRIMARY; SECONDARY | RESULT_06b40a664b37; RESULT_c4a483171921; RESULT_10e6bb07aab3 | checkable | not_assessed | reduced |
CLAIM_RESULT_d23198f25c89 | CLUST_31214ff48de12f76 | 27,103,215 | NCT01542957 | no_difference_claim | no_difference | source_reported | 3 | PRIMARY; SECONDARY | RESULT_06b40a664b37; RESULT_c4a483171921; RESULT_10e6bb07aab3 | checkable | not_assessed | no significant difference |
CLAIM_RESULT_cbf154f62ed8 | CLUST_31214ff48de12f76 | 27,103,215 | NCT01542957 | efficacy_claim | improved | directionally_supported | 3 | PRIMARY; SECONDARY | RESULT_06b40a664b37; RESULT_c4a483171921; RESULT_10e6bb07aab3 | checkable | not_assessed | efficacy |
CLAIM_RESULT_3d29c48a7108 | CLUST_1193643f5521c16f | 27,094,721 | NCT02376257 | association_claim | improved | directionally_supported | 8 | PRIMARY; SECONDARY | RESULT_c47b8691730f; RESULT_252e9c6091b5; RESULT_5baf07adb9db; RESULT_cf52d6dca146; RESULT_df16194f5c45; RESULT_1480300a439b; RESULT_3f4ebfa9db8a; RESULT_5a266b090904 | checkable | not_assessed | associated with |
CLAIM_RESULT_8febba9a395a | CLUST_82525d83a8f66080 | 27,089,521 | NCT01284517 | association_claim | associated | source_reported | 3 | PRIMARY; SECONDARY | RESULT_79b3d9c2c98b; RESULT_58a78b09c91f; RESULT_9b15cc11a377 | checkable | not_assessed | associated with |
CLAIM_RESULT_b5705d2187fd | CLUST_82525d83a8f66080 | 27,089,521 | NCT01284517 | efficacy_claim | associated | statistically_supported | 3 | PRIMARY; SECONDARY | RESULT_79b3d9c2c98b; RESULT_58a78b09c91f; RESULT_9b15cc11a377 | checkable | not_assessed | efficacy |
CLAIM_RESULT_302304667941 | CLUST_46048b14918e0028 | 27,089,159 | NCT01790919 | no_difference_claim | no_difference | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | no difference |
CLAIM_RESULT_dabff877ac1c | CLUST_46048b14918e0028 | 27,089,159 | NCT01790919 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_b2e74c1766ee | CLUST_3ab193df5bd3d7d1 | 29,689,693 | NCT01564862 | no_difference_claim | no_difference | statistically_supported | 15 | PRIMARY; SECONDARY | RESULT_3822d06fe4c9; RESULT_ae4fa4caf9e5; RESULT_9173ab000ab7; RESULT_ac3cc1a23c3f; RESULT_337a8cf17dab; RESULT_6496094d7ae0; RESULT_ef0251d71e06; RESULT_9812abe566b5; RESULT_4012de0efe7a; RESULT_3a6ab8f3a972; RESULT_848dee3ac21b; RESULT_03554ea63e5c; RESULT_8bdd650d1406; RESULT_3f4b466922e0; RESULT_efb83f88f0dc | checkable | not_assessed | did not differ |
CLAIM_RESULT_8dba2e9fa5b6 | CLUST_3ab193df5bd3d7d1 | 29,689,693 | NCT01564862 | efficacy_claim | no_difference | statistically_supported | 15 | PRIMARY; SECONDARY | RESULT_3822d06fe4c9; RESULT_ae4fa4caf9e5; RESULT_9173ab000ab7; RESULT_ac3cc1a23c3f; RESULT_337a8cf17dab; RESULT_6496094d7ae0; RESULT_ef0251d71e06; RESULT_9812abe566b5; RESULT_4012de0efe7a; RESULT_3a6ab8f3a972; RESULT_848dee3ac21b; RESULT_03554ea63e5c; RESULT_8bdd650d1406; RESULT_3f4b466922e0; RESULT_efb83f88f0dc | checkable | not_assessed | efficacy |
CLAIM_RESULT_d3f7c0097c79 | CLUST_58d7841b29dad9f8 | 29,560,909 | NCT01832805 | superiority_claim | associated | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | increased |
CLAIM_RESULT_dddd0af7398f | CLUST_58d7841b29dad9f8 | 29,560,909 | NCT01832805 | association_claim | associated | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_051537f0f8ba | CLUST_4ac918e56e5082e8 | 29,486,867 | NCT01598922 | association_claim | unclear | source_reported | 8 | PRIMARY; SECONDARY | RESULT_f5db1afc2fd7; RESULT_17c43db16ffc; RESULT_91126c763f8c; RESULT_e8503357ba91; RESULT_7c3b292ae379; RESULT_30ccae3c86cd; RESULT_e3f5dd316399; RESULT_ccf9d198e215 | checkable | not_assessed | linked to |
CLAIM_RESULT_7836cbd59497 | CLUST_f2dacb28a7eed9c1 | 29,265,831 | NCT01178424 | no_difference_claim | no_difference | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | no difference |
CLAIM_RESULT_02c41cf5fc65 | CLUST_f2dacb28a7eed9c1 | 29,265,831 | NCT01178424 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_486b2eab8513 | CLUST_981a5b8d48369aa2 | 29,229,613 | NCT01891097 | no_difference_claim | no_difference | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | no significant difference |
CLAIM_RESULT_773c97898b5e | CLUST_981a5b8d48369aa2 | 29,229,613 | NCT01891097 | safety_claim | no_difference | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | safe and |
CLAIM_RESULT_a01f7415e42d | CLUST_3ac4e5369291e685 | 29,196,478 | NCT02375308 | non_inferiority_claim | non_inferior | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | non-inferior |
CLAIM_RESULT_81f8bd810875 | CLUST_3ac4e5369291e685 | 29,196,478 | NCT02375308 | efficacy_claim | non_inferior | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_6bfc8c145ab8 | CLUST_556e5278f3115b02 | 29,185,786 | NCT01371734 | safety_claim | unclear | source_reported | 4 | PRIMARY; SECONDARY | RESULT_6bb27c90383b; RESULT_d81a7d62faae; RESULT_614b53a3937d; RESULT_d0e6b45bec06 | checkable | not_assessed | well tolerated |
CLAIM_RESULT_805e4486c5d2 | CLUST_556e5278f3115b02 | 29,185,786 | NCT01371734 | efficacy_claim | unclear | source_reported | 4 | PRIMARY; SECONDARY | RESULT_6bb27c90383b; RESULT_d81a7d62faae; RESULT_614b53a3937d; RESULT_d0e6b45bec06 | checkable | not_assessed | efficacy |
CLAIM_RESULT_c5c0975a040c | CLUST_f24c0e4537c9dd16 | 29,177,955 | NCT01655030 | efficacy_claim | unclear | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_d62927131bdd | CLUST_f415be59212dcb8d | 29,160,598 | NCT01355081 | safety_claim | improved | directionally_supported | 6 | PRIMARY; SECONDARY | RESULT_8084589ca035; RESULT_429d04c482ac; RESULT_4f921dcb6e22; RESULT_f398313dbba1; RESULT_0f38ddd74189; RESULT_559e43e7511e | checkable | not_assessed | well tolerated |
CLAIM_RESULT_53725c81cc61 | CLUST_f415be59212dcb8d | 29,160,598 | NCT01355081 | efficacy_claim | improved | directionally_supported | 6 | PRIMARY; SECONDARY | RESULT_8084589ca035; RESULT_429d04c482ac; RESULT_4f921dcb6e22; RESULT_f398313dbba1; RESULT_0f38ddd74189; RESULT_559e43e7511e | checkable | not_assessed | efficacy |
CLAIM_RESULT_bf554a1207a6 | CLUST_f415be59212dcb8d | 29,160,598 | NCT01395147 | safety_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | well tolerated |
CLAIM_RESULT_65e8d045e44b | CLUST_f415be59212dcb8d | 29,160,598 | NCT01395147 | efficacy_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_f850f6f02be6 | CLUST_46048b14918e0028 | 29,137,655 | NCT01790919 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_3c30be774e52 | CLUST_46048b14918e0028 | 29,137,655 | NCT01790919 | association_claim | improved | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_ed42800998a1 | CLUST_ef9d91bb3471cdc7 | 29,137,560 | NCT02515981 | no_difference_claim | no_difference | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | did not differ |
CLAIM_RESULT_a13f024b8322 | CLUST_ef9d91bb3471cdc7 | 29,137,560 | NCT02515981 | efficacy_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | improved outcomes |
CLAIM_RESULT_f6742ef5713b | CLUST_fe2e2890672456a8 | 29,136,600 | NCT00602537 | superiority_claim | no_difference | source_reported | 2 | PRIMARY; SECONDARY | RESULT_588b4a767263; RESULT_681e3e8577c0 | checkable | not_assessed | superior to |
CLAIM_RESULT_241107faa88c | CLUST_fe2e2890672456a8 | 29,136,600 | NCT00602537 | no_difference_claim | no_difference | source_reported | 2 | PRIMARY; SECONDARY | RESULT_588b4a767263; RESULT_681e3e8577c0 | checkable | not_assessed | no significant difference |
CLAIM_RESULT_dccefdc57012 | CLUST_fe2e2890672456a8 | 29,136,600 | NCT00602537 | association_claim | no_difference | source_reported | 2 | PRIMARY; SECONDARY | RESULT_588b4a767263; RESULT_681e3e8577c0 | checkable | not_assessed | associated with |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.